vs
Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $40.7M, roughly 1.9× PETMED EXPRESS INC). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -26.0%, a 33.4% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -23.3%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-9.2M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -20.9%).
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
PETS vs VMD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.7M | $76.2M |
| Net Profit | $-10.6M | $5.6M |
| Gross Margin | 23.3% | 57.9% |
| Operating Margin | -25.7% | 11.0% |
| Net Margin | -26.0% | 7.4% |
| Revenue YoY | -23.3% | 25.5% |
| Net Profit YoY | -1392.6% | 30.7% |
| EPS (diluted) | $-0.50 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.7M | $76.2M | ||
| Q3 25 | $44.4M | $71.9M | ||
| Q2 25 | $51.2M | $63.1M | ||
| Q1 25 | $50.8M | $59.1M | ||
| Q4 24 | $52.0M | $60.7M | ||
| Q3 24 | $58.0M | $58.0M | ||
| Q2 24 | $66.2M | $55.0M | ||
| Q1 24 | $65.1M | $50.6M |
| Q4 25 | $-10.6M | $5.6M | ||
| Q3 25 | $-8.5M | $3.5M | ||
| Q2 25 | $-34.2M | $3.2M | ||
| Q1 25 | $-11.6M | $2.6M | ||
| Q4 24 | $-707.0K | $4.3M | ||
| Q3 24 | $2.3M | $3.9M | ||
| Q2 24 | $3.8M | $1.5M | ||
| Q1 24 | $-5.0M | $1.6M |
| Q4 25 | 23.3% | 57.9% | ||
| Q3 25 | 28.0% | 57.5% | ||
| Q2 25 | 28.1% | 58.3% | ||
| Q1 25 | 29.9% | 56.3% | ||
| Q4 24 | 31.0% | 59.5% | ||
| Q3 24 | 32.3% | 59.3% | ||
| Q2 24 | 28.8% | 59.8% | ||
| Q1 24 | 29.3% | 58.9% |
| Q4 25 | -25.7% | 11.0% | ||
| Q3 25 | -18.9% | 7.8% | ||
| Q2 25 | -66.7% | 8.1% | ||
| Q1 25 | -11.9% | 6.5% | ||
| Q4 24 | -0.9% | 10.6% | ||
| Q3 24 | 1.0% | 9.7% | ||
| Q2 24 | 6.6% | 6.6% | ||
| Q1 24 | -5.9% | 4.4% |
| Q4 25 | -26.0% | 7.4% | ||
| Q3 25 | -19.2% | 4.9% | ||
| Q2 25 | -66.7% | 5.0% | ||
| Q1 25 | -22.9% | 4.4% | ||
| Q4 24 | -1.4% | 7.1% | ||
| Q3 24 | 4.0% | 6.7% | ||
| Q2 24 | 5.7% | 2.7% | ||
| Q1 24 | -7.7% | 3.2% |
| Q4 25 | $-0.50 | $0.14 | ||
| Q3 25 | $-0.41 | $0.09 | ||
| Q2 25 | $-1.65 | $0.08 | ||
| Q1 25 | $-0.56 | $0.06 | ||
| Q4 24 | $-0.03 | $0.10 | ||
| Q3 24 | $0.11 | $0.10 | ||
| Q2 24 | $0.18 | $0.04 | ||
| Q1 24 | $-0.24 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.9M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $32.8M | $141.5M |
| Total Assets | $88.0M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $13.5M | ||
| Q3 25 | $36.1M | $11.1M | ||
| Q2 25 | $41.1M | $20.0M | ||
| Q1 25 | $54.7M | $10.2M | ||
| Q4 24 | $50.1M | $17.5M | ||
| Q3 24 | $52.0M | $11.3M | ||
| Q2 24 | $46.0M | $8.8M | ||
| Q1 24 | $55.3M | $7.3M |
| Q4 25 | $32.8M | $141.5M | ||
| Q3 25 | $43.1M | $133.6M | ||
| Q2 25 | $51.5M | $139.7M | ||
| Q1 25 | $85.1M | $134.8M | ||
| Q4 24 | $96.2M | $131.4M | ||
| Q3 24 | $96.4M | $125.0M | ||
| Q2 24 | $93.5M | $119.4M | ||
| Q1 24 | $96.7M | $116.3M |
| Q4 25 | $88.0M | $199.2M | ||
| Q3 25 | $100.3M | $202.4M | ||
| Q2 25 | $109.8M | $184.6M | ||
| Q1 25 | $148.7M | $178.1M | ||
| Q4 24 | $144.8M | $177.1M | ||
| Q3 24 | $146.0M | $169.5M | ||
| Q2 24 | $152.7M | $163.9M | ||
| Q1 24 | $169.9M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.2M | $18.4M |
| Free Cash FlowOCF − Capex | $-9.2M | $9.7M |
| FCF MarginFCF / Revenue | -22.7% | 12.7% |
| Capex IntensityCapex / Revenue | 0.1% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-23.0M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.2M | $18.4M | ||
| Q3 25 | $-2.2M | $18.4M | ||
| Q2 25 | $-12.3M | $12.3M | ||
| Q1 25 | $7.0M | $2.9M | ||
| Q4 24 | $-1.2M | $15.0M | ||
| Q3 24 | $7.4M | $12.7M | ||
| Q2 24 | $-8.5M | $10.2M | ||
| Q1 24 | $7.1M | $1.2M |
| Q4 25 | $-9.2M | $9.7M | ||
| Q3 25 | $-4.8M | $10.7M | ||
| Q2 25 | $-13.6M | $4.1M | ||
| Q1 25 | $4.6M | $-12.6M | ||
| Q4 24 | $-1.9M | $3.2M | ||
| Q3 24 | $6.1M | $1.7M | ||
| Q2 24 | $-9.2M | $1.2M | ||
| Q1 24 | $5.9M | $-4.8M |
| Q4 25 | -22.7% | 12.7% | ||
| Q3 25 | -10.8% | 14.9% | ||
| Q2 25 | -26.5% | 6.5% | ||
| Q1 25 | 9.1% | -21.4% | ||
| Q4 24 | -3.7% | 5.2% | ||
| Q3 24 | 10.6% | 3.0% | ||
| Q2 24 | -13.9% | 2.3% | ||
| Q1 24 | 9.0% | -9.5% |
| Q4 25 | 0.1% | 11.5% | ||
| Q3 25 | 5.9% | 10.6% | ||
| Q2 25 | 2.5% | 12.9% | ||
| Q1 25 | 4.7% | 26.2% | ||
| Q4 24 | 1.5% | 19.5% | ||
| Q3 24 | 2.2% | 19.0% | ||
| Q2 24 | 1.0% | 16.3% | ||
| Q1 24 | 1.9% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 3.18× | 3.29× | ||
| Q2 24 | -2.27× | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
VMD
Segment breakdown not available.
